Today: 19 June 2026

American Airlines Group (AAL) Stock News Today: What’s Moving Shares on Dec. 24, 2025, Plus Analyst Forecasts and 2026 Outlook

American Airlines Group (AAL) Stock News Today: What’s Moving Shares on Dec. 24, 2025, Plus Analyst Forecasts and 2026 Outlook

American Airlines shares traded near $15.60 on Dec. 24 after falling 4% in the previous session, as investors reacted to tighter loyalty-program rules that cut rewards for basic economy fares. The stock move comes amid thin holiday trading and ongoing scrutiny of American’s efforts to boost premium offerings and close a profit gap with Delta and United.
24 December 2025
·
Waste Management (WM) Stock News on Dec. 24, 2025: Institutional Buys, Employee Trading Blackout, and a 2026 Dividend-and-Buyback Push

Waste Management (WM) Stock News on Dec. 24, 2025: Institutional Buys, Employee Trading Blackout, and a 2026 Dividend-and-Buyback Push

WM disclosed increased institutional ownership on Dec. 24, with Vontobel Holding and Swedbank AB reporting large Q3 stake boosts. A retirement-plan trading blackout begins today as the company changes recordkeepers. Investors continue to watch WM’s integration of Stericycle’s medical waste unit and upcoming $3 billion buyback and dividend increase planned for 2026.
24 December 2025
··
Plug Power PLUG Stock News Today: Analyst Targets, Hydrogen Contracts, and Dilution Risks Ahead of the 2026 Shareholder Vote (Dec. 24, 2025)

Plug Power PLUG Stock News Today: Analyst Targets, Hydrogen Contracts, and Dilution Risks Ahead of the 2026 Shareholder Vote (Dec. 24, 2025)

Plug Power shares closed at $2.05 on Dec. 23, down nearly 3%, valuing the company at about $2.9 billion. On Dec. 24, analysts split: a new Motley Fool report highlights ongoing losses and cash burn, while another upgrades the stock for the first time in five years. Consensus analyst rating remains Neutral, with a 12-month price target averaging $2.79. Plug Power’s 52-week range spans $0.69 to $4.58.
24 December 2025
·
Nike Stock Rises After Apple CEO Tim Cook Buys $3 Million Stake, Signaling Confidence in Turnaround Amid Tariffs and China Slowdown

Nike Stock Rises After Apple CEO Tim Cook Buys $3 Million Stake, Signaling Confidence in Turnaround Amid Tariffs and China Slowdown

Nike shares rose about 2% in premarket trading December 24 after an SEC filing showed Apple CEO Tim Cook bought 50,000 shares for nearly $3 million. Cook, Nike’s lead independent director, made the open-market purchase December 22 at an average price of $58.97. The move followed a post-earnings selloff and lifted sentiment despite ongoing concerns about Nike’s profitability and China sales.
24 December 2025
··
Eos Energy Enterprises Stock (EOSE) Turns Volatile After Chair Transition News as Wall Street Reprices the 2026 Ramp

Eos Energy Enterprises Stock (EOSE) Turns Volatile After Chair Transition News as Wall Street Reprices the 2026 Ramp

Eos Energy shares fell 7.21% to $11.96 on Dec. 23 after the company announced board chair Russ Stidolph will step down Dec. 31, with Joseph Nigro set to take over Jan. 1. The leadership change comes as trading volumes thin ahead of the early market close on Dec. 24, increasing volatility in the stock. Pre-market indications Wednesday showed modest gains.
24 December 2025
··
Strategy Inc Stock MSTR News and Forecasts for December 24, 2025: Cash Reserve Pivot, Bitcoin Pause, and Wall Street Targets

Strategy Inc Stock MSTR News and Forecasts for December 24, 2025: Cash Reserve Pivot, Bitcoin Pause, and Wall Street Targets

Strategy Inc shares traded around $158 on December 24 after the company disclosed it sold 4.54 million shares for $747.8 million and paused Bitcoin purchases, keeping holdings steady. The firm’s U.S. dollar reserves rose to $2.19 billion, up from $1.44 billion earlier in December. Executive Chairman Michael Saylor is promoting a shift toward a broader capital markets platform.
24 December 2025
··
United States Antimony Corporation (UAMY) Stock: Today’s Move, Latest Contracts, Analyst Forecasts, and What Investors Are Watching on Dec. 24, 2025

United States Antimony Corporation (UAMY) Stock: Today’s Move, Latest Contracts, Analyst Forecasts, and What Investors Are Watching on Dec. 24, 2025

UAMY shares jumped 7.87% on Dec. 23, 2025, closing at $6.03 after trading in a wide range on heavy volume. Pre-market quotes on Dec. 24 showed the stock near $6.13. The company remains in focus as antimony draws attention as a critical mineral for defense and supply chains. UAMY’s recent contract wins and expansion plans have fueled volatility.
24 December 2025
·
AiRWA Inc (YYAI) Stock News, Forecasts and Analysis for Dec. 24, 2025: New 10‑Q, $15.69M Offering, and Why the Tape Is So Volatile

AiRWA Inc (YYAI) Stock News, Forecasts and Analysis for Dec. 24, 2025: New 10‑Q, $15.69M Offering, and Why the Tape Is So Volatile

AiRWA Inc. (NASDAQ: YYAI) announced a $15.69 million registered direct offering at $1.02 per share, matching the Dec. 18 close. Shares traded around $1.01 pre-market Dec. 24 after closing at $0.98 the prior session. The company, formerly Connexa Sports, recently rebranded and focuses on AI software for dating and Web3 tokenization. Proceeds target a joint venture and possible acquisitions.
24 December 2025
Broadcom (AVGO) Stock News Today, Forecasts and Analysis for Dec. 24, 2025: AI Margins, Tariffs, Insider Moves and Valuation

Broadcom (AVGO) Stock News Today, Forecasts and Analysis for Dec. 24, 2025: AI Margins, Tariffs, Insider Moves and Valuation

Broadcom shares traded near $350 on Dec. 24 amid thin holiday liquidity, following a volatile December driven by strong AI demand and margin concerns. The company projected Q1 revenue of $19.1 billion but warned of a 100 basis point gross margin drop due to lower-margin AI products. Broadcom reported a $73 billion backlog, mostly from five customers. U.S. delayed new China chip tariffs until 2027.
24 December 2025
··
Teva Stock News on Dec. 24, 2025: TEVA Rallies on S&P Credit Upgrade, $40 Price Target Hike, and Fresh Pipeline Catalysts

Teva Stock News on Dec. 24, 2025: TEVA Rallies on S&P Credit Upgrade, $40 Price Target Hike, and Fresh Pipeline Catalysts

Teva shares closed at $31.54 on Dec. 23, up 28% since Nov. 5, after S&P Global Ratings upgraded the company’s credit to ‘BB+’ on improved deleveraging. The stock traded near $31.93 pre-market Dec. 24. Analysts, including Piper Sandler, have raised price targets as Teva’s pipeline and biosimilars schedule gains clarity. Investors remain alert to pricing and patent risks.
24 December 2025
··
Rezolute, Inc. (RZLT) Stock News and Forecasts on Dec. 24, 2025: Phase 3 sunRIZE Miss, Analyst Target Cuts, and What Comes Next

Rezolute, Inc. (RZLT) Stock News and Forecasts on Dec. 24, 2025: Phase 3 sunRIZE Miss, Analyst Target Cuts, and What Comes Next

Rezolute shares remain under pressure after the company’s December 11, 2025, announcement that its pivotal sunRIZE Phase 3 trial for ersodetug in congenital hyperinsulinism failed to meet primary and key secondary endpoints. The stock trades near $2.42, well below pre-trial levels, following analyst downgrades and investor-law-firm probes. Two serious hypersensitivity reactions were reported in the trial.
24 December 2025
··
Dollarama Stock (TSX: DOL) Near Fresh Highs on Dec. 24, 2025: Earnings Momentum, Global Expansion, and a Valuation Test

Dollarama Stock (TSX: DOL) Near Fresh Highs on Dec. 24, 2025: Earnings Momentum, Global Expansion, and a Valuation Test

Dollarama shares closed near C$204.69 on December 24, 2025, as the S&P/TSX approached record highs in a shortened holiday session. The stock hit fresh highs after reporting Q3 sales up 22.2% to $1.91 billion and net earnings up 16.6% to $321.7 million. Investors are debating whether its premium valuation is justified as the company expands beyond its core market.
24 December 2025
··
Reviva Pharmaceuticals (RVPH) Stock Plunges After FDA Calls for Second Phase 3 Trial: News, Forecasts, and Analyst Takeaways on Dec. 24, 2025

Reviva Pharmaceuticals (RVPH) Stock Plunges After FDA Calls for Second Phase 3 Trial: News, Forecasts, and Analyst Takeaways on Dec. 24, 2025

Reviva Pharmaceuticals shares fell to $0.32 on December 24, 2025, after the FDA recommended a second Phase 3 trial for its schizophrenia drug brilaroxazine before a New Drug Application. The company said the new trial, RECOVER-2, could cost $60 million and delay potential approval to late 2028. Reviva plans to start the trial in the first half of 2026, pending financing.
24 December 2025
···
Regencell Bioscience Holdings Limited (RGC) Stock: News, Forecasts, and Fresh Analysis for Dec. 24, 2025

Regencell Bioscience Holdings Limited (RGC) Stock: News, Forecasts, and Fresh Analysis for Dec. 24, 2025

Regencell Bioscience Holdings (RGC) surged 14% to $25.25 on Dec. 24, 2025, despite remaining a pre-revenue company. The move followed a ValueWalk article highlighting RGC’s 17,000% gain in 2025, driven by low float, momentum trading, and a recent 38-for-1 stock split. Intraday prices ranged from $22.00 to $26.33. RGC’s market cap neared $11 billion.
24 December 2025
··
Stock Market Today: U.S. Futures Dip on Christmas Eve as S&P 500 Holds Record High and GDP Surprise Trims Rate‑Cut Bets

Stock Market Today: U.S. Futures Dip on Christmas Eve as S&P 500 Holds Record High and GDP Surprise Trims Rate‑Cut Bets

The S&P 500 closed at a record 6,909.79 Tuesday, while U.S. stock futures edged lower early Wednesday ahead of a holiday-shortened session. A strong third-quarter GDP reading at 4.3% and persistent inflation are clouding the outlook for Federal Reserve rate cuts in 2026. The NYSE will close at 1 p.m. ET, with U.S. markets shut Thursday for Christmas. Key government data releases were delayed by a federal shutdown.
24 December 2025
Canopy Growth (CGC) Stock on Dec. 24, 2025: Schedule III Executive Order, MTL Cannabis Deal, and the Latest Forecasts

Canopy Growth (CGC) Stock on Dec. 24, 2025: Schedule III Executive Order, MTL Cannabis Deal, and the Latest Forecasts

Canopy Growth shares closed at $1.40 on Dec. 23, up 6.06%, after heavy trading and sharp swings throughout December. The volatility followed a Dec. 18 White House executive order directing marijuana rescheduling from Schedule I to III. Trading volume spiked to over 216 million shares on Dec. 18, with implied volatility near 143%. U.S. exchanges operated a shortened session on Dec. 24.
24 December 2025
····
Indaptus Therapeutics (INDP) Stock in Focus on Dec. 24, 2025: $6M Financing, Leadership Reset, and the Dilution Question

Indaptus Therapeutics (INDP) Stock in Focus on Dec. 24, 2025: $6M Financing, Leadership Reset, and the Dilution Question

Indaptus Therapeutics announced a $6 million preferred-stock financing with investor David Lazar, who will become chairman and co-CEO. The deal could add up to 111 million common shares if converted, pending shareholder approval. Shares jumped over 60% after hours on December 23, 2025, following the news, after closing at $1.95 in regular trading. Two directors resigned as part of the boardroom changes.
24 December 2025
··
1 … 1,217 1,218 1,219 1,220 1,221 … 2,085

Stock Market Today

  • Laureate Education Q1 Earnings Beat Estimates Amid Mixed Sector Performance
    June 19, 2026, 3:04 PM EDT. Laureate Education (NASDAQ:LAUR) reported a strong first quarter with revenues up 15.4% year-on-year to $272.6 million, beating analyst forecasts by 2.2%. The consumer discretionary education services sector, which offers products like postsecondary education and certifications, saw a 1.9% revenue beat across tracked stocks but an average share price decline of 1.2%. Laureate's CEO highlighted positive enrollment trends in Peru and Mexico and noted $105 million in share repurchases during Q1. Despite sector challenges such as regulatory scrutiny and competition from low-cost alternatives, Laureate raised its full-year adjusted earnings per share guidance, underscoring confidence in its operating momentum.

Latest articles

Netflix shares dip in shortened week, ad gains and deals in focus

Netflix shares dip in shortened week, ad gains and deals in focus

19 June 2026
Netflix closed at $77.38, down 3.7% for the week and trailing tech peers, as investors weighed a new French partnership and concerns that growth from ads, price hikes, and content deals may already be priced in; the stock’s direction now hinges on whether upcoming earnings on July 16 deliver a positive surprise.
Shopify trades lower in Toronto with Nasdaq shut, focus stays on AI move and buyback

Shopify trades lower in Toronto with Nasdaq shut, focus stays on AI move and buyback

19 June 2026
Shopify’s Toronto shares slipped 1.1% to C$152.06 as investors weighed its $5 billion buyback and new AI tools against concerns over second-quarter growth and cash flow, with U.S. shares idle for Juneteenth after a volatile week marked by a sharp midweek drop and lingering questions about the impact of AI-driven commerce on costs and demand.
Rocket Companies shares gain ahead of holiday pause as mortgage rate bets linger

Rocket Companies shares gain ahead of holiday pause as mortgage rate bets linger

19 June 2026
Rocket Companies surged 9.08% to $14.42 on heavy volume before the Juneteenth market closure, outpacing peers as 30-year mortgage rates dipped to 6.47% and homebuying demand improved. Investors are watching whether Rocket’s integration of Redfin and Mr. Cooper can deliver cost synergies and growth, with Monday’s open set to test if the rally signals lasting confidence or holiday-driven positioning.
Go toTop